ReviewThe clinical respiratory journal2022

Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia.

Eireen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.